Janssen Pharmaceutica

At Janssen Pharmaceutica, research in cardiovascular medicine focuses on conditions such as atherothrombotic and thromboembolic disorders. These studies are mainly designed to better understand how new treatments are absorbed and handled by the body, while also exploring how convenient and acceptable different formulations may be for participants.

• Evaluation of treatment behavior in the body for cardiovascular therapies
• Research involving atherothrombotic and thromboembolic disorders
• Testing the usability and acceptability of new oral formulations

Much of this work is conducted in healthy adult participants, helping the site gather early evidence that can support future development of more effective and practical cardiovascular treatments.

The Clinical Pharmacology Unit in Antwerp is also active in immune-related research, with studies linked to inflammatory conditions and plaque psoriasis. The main goal is to assess safety, tolerability, and how potential therapies move through the body, supporting the development of new approaches for immune system diseases.

• Studies in plaque psoriasis and other inflammatory conditions
• Assessment of safety and tolerability for emerging therapies
• Early research on how treatments are absorbed and eliminated

These trials help build a clearer picture of how future immunology treatments may perform before they are tested more broadly in patients.

Research in nervous system and psychiatric conditions includes work related to Alzheimer's disease and other mental disorders. The studies at this site often examine how candidate therapies behave in the body, with attention to food effects, interactions with other medicines, and overall tolerability.

• Investigation of therapies linked to Alzheimer's disease
• Studies focused on mental health and psychiatry
• Evaluation of drug behavior, absorption, and interaction potential

This area of research supports the development of new options for neurological and psychiatric care, while also helping clarify how participants respond to treatment under different conditions.

Many trials at Janssen Pharmaceutica involve healthy volunteers and healthy adult participants, reflecting a strong emphasis on early-stage clinical pharmacology. These studies are used to explore how new therapies are absorbed, distributed, and tolerated, and to compare different formulations or administration conditions.

• Studies in healthy participants to understand treatment handling in the body
• Comparisons of tablet, liquid, and injection-based formulations
• Assessment of food effects, co-administered medicines, and acceptability

This work helps support the safe development of new medicines across several therapeutic areas, with a clear focus on practical use and patient-friendly delivery.